Bank Pictet & Cie (Europe)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$691K Hold
12,000
0.01% 151
2026
Q1
$728K Sell
12,000
-1,344
-10% -$78.3K 0.02% 147
2025
Q4
$720K Buy
+13,344
New +$642K 0.01% 145
2025
Q3
Sell
-29,605
Closed -$1.37M 200
2025
Q2
$1.37M Sell
29,605
-201,895
-87% -$9.91M 0.03% 111
2025
Q1
$14.1M Hold
231,500
0.34% 61
2024
Q4
$13.1M Buy
+231,500
New +$12.9M 0.29% 62
2024
Q2
Sell
-11,250
Closed -$610K 160
2024
Q1
$610K Hold
11,250
0.02% 125
2023
Q4
$577K Sell
11,250
-600
-5% -$31.5K 0.02% 172
2023
Q3
$688K Buy
11,850
+600
+5% +$36.8K 0.02% 151
2023
Q2
$719K Hold
11,250
0.02% 160
2023
Q1
$780K Hold
11,250
0.03% 114
2022
Q4
$809K Hold
11,250
0.04% 111
2022
Q3
$800K Hold
11,250
0.04% 107
2022
Q2
$866K Sell
11,250
-1,600
-12% -$122K 0.04% 103
2022
Q1
$938K Sell
12,850
-6,475
-34% -$435K 0.04% 106
2021
Q4
$1.21M Buy
19,325
+786
+4% +$46.1K 0.04% 104
2021
Q3
$1.1M Sell
18,539
-363
-2% -$23.9K 0.04% 103
2021
Q2
$1.26M Sell
18,902
-1,204
-6% -$78.5K 0.04% 101
2021
Q1
$1.27M Sell
20,106
-392,066
-95% -$24.4M 0.05% 98
2020
Q4
$25.6M Buy
412,172
+12,172
+3% +$748K 1.25% 29
2020
Q3
$24.1M Hold
400,000
1.35% 27
2020
Q2
$23.5M Buy
400,000
+34,340
+9% +$2.05M 1.64% 25
2020
Q1
$20.4M Buy
365,660
+358,230
+4,821% +$21.9M 1.85% 20
2019
Q4
$477K Buy
+7,430
New +$426K 0.07% 104

Other funds holding BMY

Bank Pictet & Cie (Europe)'s BMY Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 12,000 shares worth $691K. The position accounts for 0.01% of the portfolio, ranked #151.

Bank Pictet & Cie (Europe) first reported a position in BMY in Q4 2019 and has held it in 24 quarters since. The position peaked at $25.6M in Q4 2020. 1,843 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 12,000 shares of Bristol-Myers Squibb worth $691K as of Q2 2026.
  • Bank Pictet & Cie (Europe) left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #151 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 24 quarters since.
  • Bank Pictet & Cie (Europe)'s Bristol-Myers Squibb position peaked at $25.6M in Q4 2020.
  • 1,843 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.